C12Q 2523/305
Denaturation or renaturation by physical action
C12Q2523/305 (Denaturation or renaturation by physical action) appears on 5 US grants and 5 published applications in this corpus.
Search patents in C12Q- Granted patents
- 5
- Published applications
- 5
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 7 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 4 | 0 |
By publication year.
Recent patents
- Systems and methods for pre-analytical substrate processing7 Nov 2023US 11,807,900 B2Genomic Health, Inc.
- Acrylamide copolymerization for sequestration and production of single-stranded nucleic acid26 Sep 2023US 11,767,523 B2Dana-Farber Cancer Institute, Inc.
- Process for detecting nucleic acid molecules by magnetic hyperthermia and assembly enabling such detection1 Aug 2023US 11,713,481 B2Centre National de la Recherche Scientifique (CNRS)
- Micromechanical DNA origami force sensor25 Jul 2023US 11,708,601 B2Carnegie Mellon University
- Enhanced utilization of surface primers in clusters17 Mar 2020US 10,590,464 B2Illumina Cambridge Limited
- Micromechanical DNA Origami Force Sensor11 Mar 2021US 2021/0071237 A1Carnegie Mellon University
- Process for Detecting Nucleic Acid Molecules by Magnetic Hyperthermia and Assembly Enabling Such Detection20 Aug 2020US 2020/0263241 A1Centre National de la Recherche Scientifique (CNRS)
- Acrylamide copolymerization for sequestration and production of single-stranded nucleic acid18 Jun 2020US 2020/0190505 A1Dana-Farber Cancer Institute, Inc.
- Systems and methods for pre-analytical substrate processing26 Dec 2019US 2019/0390252 A1Genomic Health, Inc.
- Enhanced utilization of surface primers in clusters24 May 2018US 2018/0142281 A1Illumina Cambridge Limited
Most cited
By later US patents